Systemic monocytic-MDSCs are generated from monocytes and correlate with disease progression in breast cancer patients

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Bergenfelz, Caroline ^a   Larsson, Anna Maria ^b   Von Stedingk, Kristoffer ^b   Gruvberger Saal, Sofia ^c   Aaltonen, Kristina ^c   Jansson, Sara ^c   Jernström, Helena ^c   Janols, Helena ^d   Wullt, Marlene ^d   Bredberg, Anders ^d   Rydén, Lisa ^e   Leandersson, Karin ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Translational Cancer Research LU   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d Medical Microbiology SUS LU   (Sweden)

^e Medical Microbiology SUS LU ^*  (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; AUTACOID; CYTOKINE; IMMUNOGLOBULIN RECEPTOR;

ADULT; ARTICLE; BONE MARROW CELL; BREAST CANCER; CANCER CLASSIFICATION; CANCER GROWTH; CANCER STAGING; CD4+ T LYMPHOCYTE; CELL POPULATION; CELL PROLIFERATION; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; INNATE IMMUNITY; LEUKOCYTE; LYMPH NODE METASTASIS; METASTASIS POTENTIAL; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; SEPSIS; SUPPRESSOR CELL; TUMOR VOLUME; BREAST TUMOR; CASE CONTROL STUDY; CELL COUNT; DISEASE COURSE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; T LYMPHOCYTE; TUMOR RECURRENCE;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL COUNT; CELL PROLIFERATION; CYTOKINES; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFLAMMATION MEDIATORS; MIDDLE AGED; MONOCYTES; MYELOID CELLS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES;

EID: 84930621644     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0127028     Document Type: Article

References (56)

1. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol. 2002; 3(11):991-8. doi: 10.1038/ni1102-991 PMID: 12407406.
2. Dunn GP, Old LJ, Schreiber RD. The three Es of cancer immunoediting. Annu Rev Immunol. 2004; 22:329-60. doi: 10.1146/annurev.immunol.22.012703.104803 PMID: 15032581.
3. Condeelis J, Pollard JW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell. 2006; 124(2):263-6. doi: 10.1016/j.cell.2006.01.007 PMID: 16439202.
4. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res. 1996; 56(20):4625-9. PMID: 8840975.
5. Bates GJ, Fox SB, Han C, Leek RD, Garcia JF, Harris AL, et al. Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J Clin Oncol. 2006; 24(34):5373-80. doi: 10.1200/JCO.2006.05.9584 PMID: 17135638.
6. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nature medicine. 2004; 10(9):942-9. doi: 10.1038/nm1093 PMID: 15322536.
7. Facciabene A, Motz GT, Coukos G. T-regulatory cells: key players in tumor immune escape and angiogenesis. Cancer Res. 2012; 72(9):2162-71. doi: 10.1158/0008-5472.CAN-11-3687 PMID: 22549946; PubMed Central PMCID: PMC3342842.
8. Poindexter NJ, Sahin A, Hunt KK, Grimm EA. Analysis of dendritic cells in tumor-free and tumor-containing sentinel lymph nodes from patients with breast cancer. Breast cancer research: BCR. 2004; 6(4):R408-15. doi: 10.1186/bcr808 PMID: 15217509; PubMed Central PMCID: PMC468660.
9. Treilleux I, Blay JY, Bendriss-Vermare N, Ray-Coquard I, Bachelot T, Guastalla JP, et al. Dendritic cell infiltration and prognosis of early stage breast cancer. Clin Cancer Res. 2004; 10(22):7466-74. doi: 10.1158/1078-0432.CCR-04-0684 PMID: 15569976.
10. Whiteside TL. Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention. Semin Cancer Biol. 2006; 16(1):3-15. doi: 10.1016/j.semcancer.2005.07.008 PMID: 16153857.
11. Poschke I, Kiessling R. On the armament and appearances of human myeloid-derived suppressor cells. Clinical immunology. 2012; 144(3):250-68. doi: 10.1016/j.clim.2012.06.003 PMID: 22858650.
12. Diaz-Montero CM, Salem ML, Nishimura MI, Garrett-Mayer E, Cole DJ, Montero AJ. Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol Immunother. 2009; 58(1):49-59. doi:10.1007/s00262-008-0523-4 PMID: 18446337; PubMed Central PMCID: PMC3401888.
13. Solito S, Falisi E, Diaz-Montero CM, Doni A, Pinton L, Rosato A, et al. A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells. Blood. 2011; 118(8):2254-65. doi: 10.1182/blood-2010-12-325753 PMID: 21734236; PubMed Central PMCID: PMC3709641.
14. Poschke I, Mougiakakos D, Hansson J, Masucci GV, Kiessling R. Immature immunosuppressive CD14 +HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign. Cancer Res. 2010; 70(11):4335-45. Epub 2010/05/21.0008-5472.CAN-09-3767 [pii] doi: 10.1158/0008-5472.CAN-09-3767 PMID: 20484028.
15. Vuk-Pavlovic S, Bulur PA, Lin Y, Qin R, Szumlanski CL, Zhao X, et al. Immunosuppressive CD14 +HLA-DRlow/- monocytes in prostate cancer. Prostate. 2010; 70(4):443-55. Epub 2009/11/11. doi: 10.1002/pros.21078 PMID: 19902470; PubMed Central PMCID: PMC2935631.
16. Gustafson MP, Lin Y, New KC, Bulur PA, O'Neill BP, Gastineau DA, et al. Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone. Neuro-oncology. 2010; 12(7):631-44. doi: 10.1093/neuonc/noq001 PMID: 20179016; PubMed Central PMCID: PMC2940665.
17. Yuan XK, Zhao XK, Xia YC, Zhu X, Xiao P. Increased circulating immunosuppressive CD14(+)HLA-DR (-/low) cells correlate with clinical cancer stage and pathological grade in patients with bladder carcinoma. The Journal of international medical research. 2011; 39(4):1381-91. PMID: 21986138.
18. Gros A, Turcotte S, Wunderlich JR, Ahmadzadeh M, Dudley ME, Rosenberg SA. Myeloid cells obtained from the blood but not from the tumor can suppress T-cell proliferation in patients with melanoma. Clin Cancer Res. 2012; 18(19):5212-23. doi: 10.1158/1078-0432.CCR-12-1108 PMID: 22837179.
19. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002; 23(11):549-55. Epub 2002/10/29. S1471490602023025 [pii]. PMID: 12401408.
20. Kusmartsev S, Gabrilovich DI. Immature myeloid cells and cancer-associated immune suppression. Cancer Immunol Immunother. 2002; 51(6):293-8. doi: 10.1007/s00262-002-0280-8 PMID: 12111117.
21. Gabrilovich DI, Chen HL, Girgis KR, Cunningham HT, Meny GM, Nadaf S, et al. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nature medicine. 1996; 2(10):1096-103. PMID: 8837607.
22. Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol. 2012; 12(4):253-68. doi: 10.1038/nri3175 PMID: 22437938; PubMed Central PMCID: PMC3587148.
23. Cuenca AG, Delano MJ, Kelly-Scumpia KM, Moreno C, Scumpia PO, Laface DM, et al. A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma. Molecular medicine. 2011; 17(3-4):281-92. doi: 10.2119/molmed.2010.00178 PMID: 21085745; PubMed Central PMCID: PMC3060988.
24. Hotchkiss RS, Moldawer LL. Parallels between cancer and infectious disease. The New England journal of medicine. 2014; 371(4):380-3. doi: 10.1056/NEJMcibr1404664 PMID: 25054723.
25. Biswas SK, Lopez-Collazo E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol. 2009; 30(10):475-87. Epub 2009/09/29. S1471-4906(09)00154-9 [pii] doi: 10.1016/j.it.2009.07.009 PMID: 19781994.
26. Pena OM, Pistolic J, Raj D, Fjell CD, Hancock RE. Endotoxin tolerance represents a distinctive state of alternative polarization (M2) in human mononuclear cells. J Immunol. 2011; 186(12):7243-54. doi: 10.4049/jimmunol.1001952 PMID: 21576504.
27. Porta C, Rimoldi M, Raes G, Brys L, Ghezzi P, Di Liberto D, et al. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB. Proc Natl Acad Sci U S A. 2009; 106(35):14978-83. Epub 2009/08/27. 0809784106 [pii] doi: 10.1073/pnas.0809784106 PMID: 19706447; PubMed Central PMCID: PMC2736429.
28. Janols H, Bergenfelz C, Allaoui R, Larsson AM, Ryden L, Bjornsson S, et al. A high frequency of MDSCs in sepsis patients, with the granulocytic subtype dominating in gram-positive cases. J Leukoc Biol. 2014. doi: 10.1189/jlb.5HI0214-074R PMID: 24929004.
29. Bergenfelz C, Medrek C, Ekstrom E, Jirstrom K, Janols H, Wullt M, et al. Wnt5a induces a tolerogenic phenotype of macrophages in sepsis and breast cancer patients. J Immunol. 2012; 188(11):5448-58. Epub 2012/05/02. jimmunol.1103378 [pii] 10.4049/jimmunol.1103378. 22547701. doi: 10.4049/jimmunol.1103378 PMID: 22547701
30. Meyer TP, Zehnter I, Hofmann B, Zaisserer J, Burkhart J, Rapp S, et al. Filter Buffy Coats (FBC): a source of peripheral blood leukocytes recovered from leukocyte depletion filters. J Immunol Methods. 2005; 307(1-2):150-66. Epub 2005/12/06. S0022-1759(05)00339-X [pii] doi: 10.1016/j.jim.2005.10.004 PMID: 16325197.
31. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome biology. 2002; 3(7):RESEARCH0034. PMID: 12184808; PubMed Central PMCID: PMC126239.
32. Vallon-Christersson J, Nordborg N, Svensson M, Hakkinen J. BASE-2nd generation software for microarray data management and analysis. BMC bioinformatics. 2009; 10:330. doi: 10.1186/1471-2105-10-330 PMID: 19822003; PubMed Central PMCID: PMC2768720.
33. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, et al. TM4: a free, open-source system for microarray data management and analysis. BioTechniques. 2003; 34(2):374-8. PMID: 12613259.
34. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A. 2001; 98(9):5116-21. doi: 10.1073/pnas.091062498 PMID: 11309499; PubMed Central PMCID: PMC33173.
35. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature protocols. 2009; 4(1):44-57. doi: 10.1038/nprot.2008.211 PMID: 19131956.
36. Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009; 37(1):1-13. doi: 10.1093/nar/gkn923 PMID: 19033363; PubMed Central PMCID: PMC2615629.
37. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005; 102(43):15545-50. doi: 10.1073/pnas.0506580102 PMID: 16199517; PubMed Central PMCID: PMC1239896.
38. Xu PB, Lou JS, Ren Y, Miao CH, Deng XM. Gene expression profiling reveals the defining features of monocytes from septic patients with compensatory anti-inflammatory response syndrome. The Journal of infection. 2012; 65(5):380-91. doi: 10.1016/j.jinf.2012.08.001 PMID: 22885911.
39. Fingerle G, Pforte A, Passlick B, Blumenstein M, Strobel M, Ziegler-Heitbrock HW. The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients. Blood. 1993; 82(10):3170-6. Epub 1993/11/15. PMID: 7693040.
40. Mougiakakos D, Jitschin R, von Bahr L, Poschke I, Gary R, Sundberg B, et al. Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation. Leukemia. 2013; 27(2):377-88. doi: 10.1038/leu.2012.215 PMID: 22828446.
41. Buechler C, Ritter M, Orso E, Langmann T, Klucken J, Schmitz G. Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli. J Leukoc Biol. 2000; 67(1):97-103. PMID: 10648003.
42. Medrek C, Ponten F, Jirstrom K, Leandersson K. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients. BMC Cancer. 2012; 12:306. Epub 2012/07/25. 1471-2407-12-306 [pii] doi: 10.1186/1471-2407-12-306 PMID: 22824040; PubMed Central PMCID: PMC3414782.
43. Zhao F, Hoechst B, Duffy A, Gamrekelashvili J, Fioravanti S, Manns MP, et al. S100A9 a new marker for monocytic human myeloid-derived suppressor cells. Immunology. 2012; 136(2):176-83. doi: 10.1111/j.1365-2567.2012.03566.x PMID: 22304731; PubMed Central PMCID: PMC3403264.
44. Aneja RK, Tsung A, Sjodin H, Gefter JV, Delude RL, Billiar TR, et al. Preconditioning with high mobility group box 1 (HMGB1) induces lipopolysaccharide (LPS) tolerance. J Leukoc Biol. 2008; 84(5):1326-34. doi: 10.1189/jlb.0108030 PMID: 18687905; PubMed Central PMCID: PMC2567896.
45. Li S, Luo C, Yin C, Peng C, Han R, Zhou J, et al. Endogenous HMGB1 is required in endotoxin tolerance. The Journal of surgical research. 2013. doi: 10.1016/j.jss.2013.05.062 PMID: 23866790.
46. Hadler-Olsen E, Winberg JO, Uhlin-Hansen L. Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2013; 34(4):2041-51. doi: 10.1007/s13277-013-0842-8 PMID: 23681802.
47. Aaroe J, Lindahl T, Dumeaux V, Saebo S, Tobin D, Hagen N, et al. Gene expression profiling of peripheral blood cells for early detection of breast cancer. Breast cancer research: BCR. 2010; 12(1):R7. doi:10.1186/bcr2472 PMID: 20078854; PubMed Central PMCID: PMC2880427.
48. Sharma P, Sahni NS, Tibshirani R, Skaane P, Urdal P, Berghagen H, et al. Early detection of breast cancer based on gene-expression patterns in peripheral blood cells. Breast cancer research: BCR. 2005; 7(5):R634-44. doi: 10.1186/bcr1203 PMID: 16168108; PubMed Central PMCID: PMC1242124.
49. Szabo KA, Singh G. Modulation of monocyte matrix metalloproteinase-2 by breast adenocarcinoma cells. Breast cancer research: BCR. 2005; 7(5):R661-8. doi: 10.1186/bcr1261 PMID: 16168111; PubMed Central PMCID: PMC1242127.
50. Mohamed MM, Cavallo-Medved D, Sloane BF. Human monocytes augment invasiveness and proteolytic activity of inflammatory breast cancer. Biological chemistry. 2008; 389(8):1117-21. doi: 10.1515/BC.2008.117 PMID: 18710343; PubMed Central PMCID: PMC3402350.
51. Blot E, Chen W, Vasse M, Paysant J, Denoyelle C, Pille JY, et al. Cooperation between monocytes and breast cancer cells promotes factors involved in cancer aggressiveness. British journal of cancer. 2003; 88(8):1207-12. doi: 10.1038/sj.bjc.6600872 PMID: 12698185; PubMed Central PMCID: PMC2747575.
52. Evani SJ, Prabhu RG, Gnanaruban V, Finol EA, Ramasubramanian AK. Monocytes mediate metastatic breast tumor cell adhesion to endothelium under flow. FASEB J. 2013; 27(8):3017-29. doi: 10.1096/fj.12-224824 PMID: 23616566; PubMed Central PMCID: PMC3714575.
53. Mages J, Dietrich H, Lang R. A genome-wide analysis of LPS tolerance in macrophages. Immunobiology. 2007; 212(9-10):723-37. doi: 10.1016/j.imbio.2007.09.015 PMID: 18086374.
54. Austermann J, Friesenhagen J, Fassl SK, Ortkras T, Burgmann J, Barczyk-Kahlert K, et al. Alarmins MRP8 and MRP14 Induce Stress Tolerance in Phagocytes under Sterile Inflammatory Conditions. Cell reports. 2014; 9(6):2112-23. doi: 10.1016/j.celrep.2014.11.020 PMID: 25497086.
55. Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med. 2006; 203(7):1701-11. doi: 10.1084/jem.20060772 PMID: 16818678; PubMed Central PMCID: PMC2118339.
56. Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, et al. Nomenclature of monocytes and dendritic cells in blood. Blood. 2010; 116(16):e74-80. Epub 2010/07/16. blood-2010-02-258558 [pii] doi: 10.1182/blood-2010-02-258558 PMID: 20628149.